N/A
Completed N=1,071
BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity
Source: ClinicalTrials.gov NCT05051631 ↗Enrolled (actual)
1,071
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcomePrimary: Number of Eligible Women Who Received Breast Cancer Risk Assessment — 8; 56; 29 Participants
Summary
The central goal of this study is to test strategies to implement evidence-based breast cancer risk assessment in healthcare clinics in Tennessee. The BRAVE Strategy (Breast cancer Risk Assessment - achieVing Equity) study aims to assess the feasibility, reach, acceptability, and appropriateness of select customized strategies to increase uptake of breast cancer risk assessment. The investigators will achieve these aims through a conducting a stepped-wedge trial conducted in 10 healthcare clinics in the state of Tennessee. The primary outcome is the proportion of women age 25-49 having risk assessment. Secondary outcomes include the numbers of 1) women identified as high-risk; 2) pursuing risk-adherent screening; and 3) diagnosed with breast cancer.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Eligible Women Who Received Breast Cancer Risk Assessment |
8; 56; 29 | — |
| SECONDARY Number of Women Who Received Risk Assessment Who Were Identified as High Risk for Breast Cancer. |
0; 3; 4 | — |
| SECONDARY Number of Women Identified as High Risk Women Who Received Breast Cancer Screening. |
0; 2; 2 | — |
| SECONDARY Number of Cancers Detected in Women Identified at High Risk. |
0; 1; 0 | — |
Eligibility Criteria
Inclusion Criteria
- ages 25-49
Exclusion Criteria
- personal history of breast cancer
Data sourced from ClinicalTrials.gov (NCT05051631). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.